ADMA Biologics Inc (NASDAQ:ADMA)

3.89
Delayed Data
As of Feb 21
 +0.03 / +0.78%
Today’s Change
2.01
Today|||52-Week Range
5.44
+21.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues3.3M2.6M3.4M4.7M
 
 
 
 
 
Cost of Goods Sold3.3M3.0M5.7M12.3M
 
 
 
 
 
Depreciation And Amortization117.9K118.1K277.1K836.1K
 
 
 
 
 
 
Operating ExpensesGross Income-77.2K-466.9K-2.6M-8.4M
 
 
 
 
 
General Expenses3.9M5.5M5.8M6.0M
 
 
 
 
 
Research And Development583.4K1.2M1.4M1.8M
 
 
 
 
 
Total Operating Expenses7.3M8.6M11.8M19.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-5.9M-8.4M-14.4M
 
 
 
 
 
Interest Expense On Debt628.2K618.5K642.5K783.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.6M-6.5M-9.0M-15.2M
 
 
 
 
 
Net Income-4.6M-6.5M-9.0M-15.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS----16.4M25.8M
 
 
 
Shares To Calculate EPS Diluted----16.4M25.8M
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.51-$0.55-$0.59
 
 
 
 
 
EPS Diluted-----$0.55-$0.59